China MedTech Market Overview, 2030

Since the implementation of the Health China 2030 policy, a national framework with the goal of improving public health services and increasing access to sophisticated medical technologies, the MedTech industry in China has experienced significant change. By promoting investments in domestic innovation, regulatory reform, and infrastructure improvements, this strategic initiative transformed MedTech from a peripheral industry to a cornerstone of the nation's healthcare modernization. Special attention was paid to disease prevention, elderly care, and intelligent healthcare all of which were important factors in the rapid integration of medical devices and digital health technologies. One of China's biggest healthcare issues is its aging population, and MedTech has responded with specialized treatments. These tools, which include home blood pressure monitors and ECGs, as well as telehealth platforms and AI-powered fall detection systems, are essential for treating chronic conditions prevalent in older adults. These technologies are increasingly used by home healthcare providers and geriatric hospitals to provide proactive, cost-effective treatment. The development of AI diagnostic tools, particularly in pathology and radiology, accelerated during the 2017–2020 period thanks to state funding and a favorable regulatory climate. In rural China, where there is a lack of skilled healthcare workers, AI aids in filling diagnostic gaps in CT, MRI, and X-ray interpretation. To incorporate AI into clinical processes, firms such Infervision and YITU Tech have worked with hospitals all over the nation. One other significant frontier is wearable technology. Smartwatches from companies like Huawei and Xiaomi that have heart rate and SpO2 sensors are now extensively utilized for health monitoring, especially in metropolitan areas. Increased freedom, early disease identification, and lifestyle management tools are all made possible for consumers thanks to the growth of digital infrastructure and health apps.

According to the research report, ""China MedTech Market Overview, 2030,"" published by Bonafide Research, the China MedTech market is anticipated to grow at more than 6.44% CAGR from 2025 to 2030. The factors driving this expansion include an aging population, increasing healthcare demand, digital transformation, and government support. Government support through programs like ""Made in China 2025"" and ""Healthy China 2030"" has aided domestic businesses in their rapid growth and development of their creative capacity, with local manufacturing gradually taking the place of imports. The country's quick transition towards intelligent healthcare is evident in recent approvals by the China Food and Drug Administration CFDA, which has since been restructured as the National Medical Products Administration NMPA. With regulatory approval for clinical application, AI-powered diagnostic tools such as InferRead CT developed by Infervision and YITU's Medical Imaging System have allowed hospitals around China to use machine learning to detect lung nodules, strokes, and other important disorders with higher accuracy and speed. The top Chinese medical technology companies, like Yuyue Medical and Mindray Medical, have established themselves as significant players in the market. Yuyue focuses on at-home medical equipment, such as thermometers, blood pressure monitors, and oxygen concentrators, whereas Mindray is well-known for its life support systems, patient monitoring, and medical imaging. Their accomplishment comes from fusing affordability with strong research and development, and both have benefited from the expansion of the export and domestic markets. Improving rural health access, where medical facilities are less developed than in metropolitan areas, presents significant opportunities. In order to enhance early detection and treatment in underserved communities, telemedicine kits, handheld ultrasound equipment, and AI-backed diagnostics are being used as MedTech tools. CFDA and NMPA compliance guarantees the security, effectiveness, and excellence of products. Obtaining accreditation under China's regulatory framework is essential for producers to gain public confidence and access to hospital purchases.

China's MedTech market by type is divided into Medical Devices MDs, In Vitro Diagnostics IVDs, Digital Health and Care and others. Particularly in diagnostic imaging and cardiovascular devices, the MD sector gains greatly from its local manufacturing capabilities and export prospects. Driven by the COVID-19 pandemic and continuous attempts to improve early disease diagnosis, in vitro diagnostics IVDs are now one of the quickest expanding categories. Molecular test kits, immunoassays, and point-of-care diagnostics are being produced by rapidly growing Chinese IVD companies like BGI Genomics and Wondfo. The need for quick and reliable testing methods has increased even more as a result of government support for routine screening and chronic disease management, notably in the fields of cancer, infectious disease, and metabolic disorders. With the advent of AI, big data analytics, cloud-based platforms, and telemedicine, which are revolutionizing healthcare delivery, Digital Health and Care is becoming a major player in the MedTech industry. Digital platforms for remote consultations, chronic disease management, and AI-enabled diagnostic assistance have been integrated by startups and tech behemoths such as Alibaba Health and Ping An Good Doctor. Particularly among young and middle-aged people in urban China, health applications and wearables are becoming increasingly popular. The category of others includes assistive devices, rehabilitation equipment, and novel technologies like 3D-printed implants and robotic surgery systems. With supportive policies and venture capital, R&D centers in Beijing, Shanghai, and Shenzhen are supporting these advances.

Given China's high burden of cardiovascular diseases, the number one cause of death in the country, cardiology is one of the most important application areas. In particular in metropolitan areas, hospitals have widely accepted implantable pacemakers, sophisticated stents, and remote cardiac monitoring equipment. Major players in cardiovascular innovation, such as MicroPort and Lepu Medical, provide solutions that are both domestically and internationally available. The aging population and rising orthopedic disorders such fractures and osteoarthritis are driving the continuous growth of orthopedics. Joint replacement systems, spinal implants, and robotic-assisted surgical instruments are all provided by multinational corporations and Chinese enterprises. Rehabilitative technology is also becoming more popular, particularly in Tier 2 and Tier 3 cities, with the help of government-supported programs for the elderly. Due to the increasing prevalence of cancer, oncology is now a high priority. Early screening, diagnostic imaging such as PET and CT scans, and targeted therapy delivery systems are the main areas of focus for MedTech advancements. The accuracy of cancer detection has increased thanks to AI-driven imaging technologies and in vitro diagnostic tests. To improve treatment outcomes, especially in lung, breast, and colorectal malignancies, both startups and established companies are combining precision medicine with AI. As instances of dementia and stroke increase with an aging population, neurology applications are becoming more and more crucial. Neurostimulation devices, smart rehabilitation gear, and wearable EEGs are all used to treat neurological conditions. In order to facilitate the early diagnosis of illnesses like Alzheimer's and Parkinson's, hospitals in large cities are implementing AI-driven platforms. Due to increasing COPD incidence and pollution-related lung problems, there was a huge need for respiratory technology, especially ventilators and oxygen therapy equipment, during the COVID-19 pandemic, and demand for it is still rising.

Medical technologies are still primarily used in hospitals and clinics, particularly in big tertiary hospitals located in cities like Beijing, Shanghai, and Guangzhou. These organizations fuel the market for cutting-edge imaging systems, robotic surgical devices, AI-based diagnostic platforms, and high-precision in vitro diagnostics IVDs. As part of the ""Healthy China 2030"" strategy, the government has prioritized investing in state-of-the-art technologies for public hospitals in order to enhance the availability and quality of healthcare. In China's MedTech industry, ambulatory surgical centers ASCs are becoming a more prominent presence. ASCs offer effective, less expensive environments for outpatient treatments as healthcare changes seek to ease the strain on overcrowded hospitals. There is an increasing need for day-care surgical kits, mobile imaging systems, and minimally invasive equipment. The proliferation of private ASCs in urban areas, particularly in economically developed provinces like Guangdong and Zhejiang, is opening up prospects for businesses that specialize in manufacturing specialized devices. Following COVID, there has been a notable increase in the popularity of home healthcare, particularly for the treatment of chronic illnesses and the care of the elderly. There is increasing acceptance of home-use MedTech items such as wearable monitors, portable ECGs, glucose meters, smart thermometers, and digital rehabilitation devices among the more than 260 million individuals who are 60 or older. Home-based treatment is becoming a driving force behind China's MedTech industry as tech-savvy customers utilize digital health solutions offered by companies like Ping An Good Doctor and JD Health. The diagnostics and IVD industry relies heavily on both public and commercial diagnostic labs.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• MedTech Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Type
• Medical Devices (MDs)
• In Vitro Diagnostics (IVDs)
• Digital Health and Care
• Others

By Application
• Cardiology
• Orthopedics
• Oncology
• Neurology
• Respiratory
• Others

By End-user
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Healthcare
• Diagnostic Laboratories Show more